| Literature DB >> 35989909 |
Julie M Joyce1,2,3,4, Chantel T Debert2,3,4,5, Mathilde Chevignard6,7,8, Gilad Sorek9, Michal Katz-Leurer9, Isabelle Gagnon10,11,12, Kathryn J Schneider2,3,4,13,14.
Abstract
Left untreated, balance impairment following moderate-to-severe traumatic brain injury (TBI) can be highly debilitating and hinder activities of daily life. To detect impairments, clinicians need appropriate assessment tools. The objective of this study was to evaluate the feasibility and utility of a battery of clinical balance assessments in adults with moderate-to-severe TBI within 6-months of injury. Thirty-seven adults with TBI [Glasgow Coma Scale score ≤ 12 (33 M/4 F) age 18-50 years] participated in balance testing. Assessments included the Balance Error Scoring System (BESS), National Institutes of Health Standing Balance Test (NIH-SBT), Functional Gait Assessment (FGA), Advanced Functional Gait Assessment (FGA-A), Tandem Gait Test (TGT), Berg Balance Scale (BBS), and Walking While Talking Test (WWTT). We identified pronounced ceiling effects on the BBS and FGA, two widely used clinical balance assessments. The NIH-SBT, WWTT, and FGA used in conjunction with the FGA-A, offered versatility in their capacity to assess patients across the balance severity spectrum. This study provides evidence to support a stepwise approach to balance assessment that can be adapted to the broad range of balance ability found in moderate-to-severe TBI.Entities:
Keywords: balance; dual-task; gait; postural stability; traumatic brain injury
Year: 2022 PMID: 35989909 PMCID: PMC9381921 DOI: 10.3389/fneur.2022.906697
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Descriptive summary of balance test protocols and scoring of assessments included in the SiMPly Rehab balance testing battery.
|
|
|
|
|---|---|---|
| BESS ( | Participants are scored on the number of errors made (deviations from proper stance) for a maximum of 10 errors per pose. | |
| NIH-SBT ( | Scores are generated automatically by NIH software. Three scores were used for data analysis: | |
| FGA ( | Performance for each task is scored on an ordinal scale from 0 to 3 with lower scores indicative of greater impairment. | |
| FGA-A ( | Performance for each task is scored on an ordinal scale from 0 to 3 with lower scores indicative of greater impairment. | |
| TGT ( | Best time of four trials used for scoring. Shorter times reflect better performance. | |
| BBS ( | Performance of each task is scored on a five-point scale range from 0 to 4. A score of 0 is indicative of the lowest level of function and a score of 4 is indicative of the highest level of function. | |
| 12) place alternate foot on step or stool while standing unsupported | ||
| WWTT ( | Reduced performance in dual task conditions (task 2 and 3) is described as dual task cost (DTC). Relative DTC is calculated as follows: |
Detailed descriptions of protocols and scoring can be found in references cited for each assessment. BESS, Balance Error Scoring System; NIH-SBT, National Institutes of Health Standing Balance Test; FGA, Functional Gait Assessment; FGA-A, Advanced Functional Gait Assessment; BBS, Berg Balance Scale; TGT, Tandem Gait Test; WWTT, Walking While Talking Test.
Patient characteristics of adults with TBI who participated in balance testing (n = 37).
|
|
|
|
| |
|---|---|---|---|---|
| Sex, M/F | 33 M/4 F | - | - | - |
| Age (years) | 26.52 | 20.77–35.70 | 18.36 | 50.83 |
| Time since injury (days) | 93 | 68–118 | 18 | 182 |
| GCS (post-injury) | 5 | 3–7 | 3 | 12 |
| GOS-E (at assessment) | 5 | 4–5 | 3 | 8 |
| Coma duration (days) | 7 | 2–15 | 0 | 35 |
| Current living situation, | ||||
| Home | 13 (35.1) | |||
| Rehabilitation hospital | 24 (64.9) | |||
| Site of assessment, | ||||
| Canada | 9 (24.3) | |||
| France | 25 (67.6) | |||
| Israel | 3 (8.1) | |||
| Evidence of skull fracture, | ||||
| Yes | 22 (50.0) | |||
| No | 7 (15.9) | |||
| Not reported | 15 (34.1) | |||
| Evidence of intracranial injury, | ||||
| Epidural hematoma | 2 (5.4) | |||
| Extraaxial hematoma | 1 (2.7) | |||
| Subdural hematoma | 6 (16.2) | |||
| Subarachnoid hemorrhage | 5 (13.5) | |||
| Contusion | 2 (5.4) | |||
| Intracerebral hemorrhage | 16 (43.2) | |||
| Diffuse axonal injury | 4 (10.8) | |||
| Not reported | 1 (2.7) |
GCS, Glasgow Coma Scale; GOS-E, Glasgow Outcome Scale Extended.
Neurological exam results of individuals who participated in balance testing.
|
|
|
|
|---|---|---|
|
| ||
| CN I | 37 | 0 (0.0) |
| CN II | 37 | 2 (5.4) |
| CN III | 37 | 6 (16.2) |
| CN IV | 37 | 5 (13.5) |
| CN V | 35 | 5 (14.2) |
| CN VI | 37 | 2 (5.4) |
| CN VII | 37 | 7 (18.9) |
| CN VIII | 37 | 3 (8.1) |
| CN IX | 37 | 2 (5.4) |
| CN X | 37 | 1 (2.7) |
| CN XI | 37 | 2 (5.4) |
| CN XII | 36 | 0 (0.0) |
|
| ||
| Dysdiadochokinesia UE | 36 | 8 (22.0) |
| Dysdiadochokinesia LE | 35 | 6 (17.1) |
| Dysmetria UE | 36 | 7 (19.4) |
| Dysmetria LE | 35 | 6 (17.1) |
| Ataxia | 37 | 3 (8.1) |
|
| ||
| Clonus UE | 36 | 1 (2.8) |
| Clonus LE | 36 | 9 (2.5) |
| Babinski | 35 | 5 (14.3) |
|
| 36 | 4 (11.1) |
|
| ||
| Biceps | 37 | 12 (32.4) |
| Triceps | 37 | 11 (29.7) |
| Achilles | 37 | 10 (27.0) |
|
| ||
| Hip flexors | 35 | 6 (17.1) |
| Knee extensors | 35 | 8 (22.9) |
| Dorsiflexors | 35 | 8 (22.9) |
| Elbow flexors | 35 | 9 (25.7) |
| Elbow extensors | 35 | 11 (26.8) |
| Wrist extensors | 35 | 10 (28.6) |
| Interosseous muscles | 35 | 11 (31.4) |
|
| ||
| Light touch UE | 37 | 6 (16.2) |
| Light touch LE | 37 | 3 (8.1) |
|
| ||
| Hemiparesis | 37 | 6 (16.2) |
| Quadriparesis | 37 | 2 (5.4) |
| Spasticity | 35 | 9 (25.7) |
| Hypotonia | 35 | 1 (2.9) |
| Visuospatial neglect | 37 | 1 (2.7) |
| Hemianopia | 32 | 5 (15.6) |
| Visual extinction | 31 | 0 (0.0) |
CN, cranial nerve; LE, lower extremity; UE, upper extremity.
Descriptive summary of clinical balance assessment feasibility and test scores.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| BESS | 37 | 28 (75.7) | 0–60 | 19 | 11–34 | 0.949 (0.192) | <10th percentile (healthy adults) | 15 (53.6) |
| NIH-SBTage−corrected | 34 | 34 (100.0) | 59–140 | 83 | 72–90 | 0.949 (0.112) | <10th percentile ( ≤ 80-healthy adults) | 15 (42.8) |
| NIH-SBT | 34 | 34 (100.0) | - | 1.35 | 1.16–1.51 | 0.989 (0.979) | Undefined | - |
| NIH-SBTratio2 | 34 | 27 (79.4) | - | 2.57 | 1.94–3.50 | 0.925 (0.052) | Undefined | - |
| FGA | 37 | 35 (94.6) | 0–30 | 28 | 18–29 | 0.801 (<0.001) | ≤ 27 (subnormal function–healthy adults) | 15 (42.8) |
| FGA-A | 37 | 25 (67.6) | 0–18 | 12 | 9–17 | 0.898 (0.017) | Undefined | - |
| TGTa | 37 | 25 (67.6) | - | 28 s | 24–40 s | 0.880 (0.008) | > 14 s (athletes with mild TBI) | 25 (100.0) |
| BBS | 37 | 35 (94.6) | 0–56 | 56 | 53–56 | 0.654 (<0.001) | ≤ 45 (fall risk–older adults) | 4 (10.8) |
| WWTT | 37 | 29 (78.4) | ||||||
| Time | - | 14 s | 10–17 s | 0.792 (<0.001) | ≥ 20 s (fall risk–older adults) | 4 (13.8) | ||
| Dual task cost | - | 0% | 0–17% | 0.859 (0.002) | Undefined | - | ||
| WWTT | 37 | 29 (78.4) | ||||||
| Time | - | 18 s | 13–24 s | 0.810 (<0.001) | ≥ 33 s (fall risk–older adults) | 4 (13.8) | ||
| Dual task cost | - | 29% | 14–56% | 0.919 (0.038) | Undefined | - |
Existing thresholds of impairment and target population are described. Balance Error Scoring System (BESS) thresholds vary with age and can be found in Iverson et al. (29). Scoring references are included in Table 1. a1 extreme outlier (> 3*IQR from Q1 or Q3) excluded from analyses. b2 extreme outliers excluded from analyses. Q1, first quartile; Q3, third quartile.
Figure 1Histograms presenting score distributions of all balance measures included in the SiMPly Rehab testing battery. One extreme outlier (> 3*IQR from Q1 or Q3) was excluded on the NIH-SBTratio1 and TGT. Two extreme outliers were excluded on the WWTT-simple and WWTT-complex. NC: Assessment not completed; Q1: first quartile; Q3: third quartile.
Spearman correlation matrix across balance assessments.
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| BESS | - | |||||||||
| NIH-SBTage−corrected | −0.417* | - | ||||||||
| NIH-SBT | 0.506** | 0.138 | - | |||||||
| NIH-SBTratio2 | −0.046 | 0.248 | 0.344 | - | ||||||
| FGA | −0.546** | 0.465** | −0.149 | −0.022 | - | |||||
| FGA-A | −0.550** | 0.390 | −0.220 | −0.073 | 0.733*** | - | ||||
| TGTa | 0.068 | −0.527** | −0.245 | −0.195 | −0.576** | −0.473* | - | |||
| BBS | −0.282 | 0.640*** | 0.001 | −0.040 | 0.739*** | 0.325 | −0.585** | - | ||
| WWTT | −0.001 | −0.448* | −0.088 | −0.273 | −0.316 | −0.213 | 0.282 | −0.362 | - | |
| WWTT | 0.071 | −0.140 | −0.048 | −0.317 | −0.395* | −0.463* | 0.390 | −0.101 | 0.313 | - |
All analyses were two-tailed. Relative dual task cost was used for WWTT-simple and WWTT-complex correlational analyses. Dashes along the diagonal represent perfect correlation (rs = 1). p < 0.05; ** p < 0.01; *** p < 0.001. a1 extreme outlier (> 3*IQR from Q1 or Q3) excluded from analyses. b2 extreme outliers excluded from analyses. Q1, first quartile; Q3, third quartile.